Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Kunz, P. L. Carcinoid and neuroendocrine tumors: building on success. J. Clin. Oncol. 33, 1855–63 (2015).
Kandoth, C. et al. Mutational landscape and significance across 12 major cancer types. Nature 502, 333–9 (2013).
Pugh, T. J. et al. The genetic landscape of high-risk neuroblastoma. Nat. Genet. 45, 279–84 (2013).
Sausen, M. et al. Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma. Nat. Genet. 45, 12–17 (2013).
Jiao, Y. et al. DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 331, 1199–203 (2011).
Fernandez-Cuesta, L. et al. Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids. Nat. Commun. 5, 3518 (2014).
Lee, I. H. et al. Ahnak functions as a tumor suppressor via modulation of TGFβ/Smad signaling pathway. Oncogene 33, 4675–84 (2014).
Draheim, K. M. et al. ARRDC3 suppresses breast cancer progression by negatively regulating integrin β4. Oncogene 29, 5032–47 (2010).
Takeda, H. et al. Transposon mutagenesis identifies genes and evolutionary forces driving gastrointestinal tract tumor progression. Nat. Genet. 47, 142–50 (2015).
Cao, Y. et al. Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1. Nat. Commun. 4, 2810 (2013).
Acknowledgements
We thank Dr. Huanming Yang, Dr. Qiang Gao, Mr. Xuanlin Huang and Ms. Peina Du at BGI-Shenzhen for the helpful discussion. This work is supported by the National Natural Science Foundation of China (81522032 to Y.C. and 81530020 to G.N.), the National Key Research and Development Program (2016YFC0905001 and 2017YFC0909703 to Y.C.), the Shanghai Rising-Star Program (15QA1402900 to Y.C.) and the National Human Genome Research Institute (U01HG006517 to L.D.).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Cao, Y., Zhou, W., Li, L. et al. Pan-cancer analysis of somatic mutations across 21 neuroendocrine tumor types. Cell Res 28, 601–604 (2018). https://doi.org/10.1038/s41422-018-0019-5
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41422-018-0019-5
